- €693.16m
- €679.33m
- BGN147.48m
- 92
- 10
- 100
- 79
2019 December 31st | 2020 December 31st | R2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 33.5 | 46.5 | 59.7 | 93.5 | 147 |
Cost of Revenue | |||||
Gross Profit | 19.5 | 37.4 | 53.5 | 84.4 | 131 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 33.3 | 35 | 42.4 | 73.8 | 109 |
Operating Profit | 0.131 | 11.5 | 17.4 | 19.6 | 38 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 8.32 | 14.9 | 18.7 | 20.2 | 37.5 |
Provision for Income Taxes | |||||
Net Income After Taxes | 7.3 | 13.4 | 15.9 | 17.4 | 32.9 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 7.17 | 13.9 | 15.9 | 17.4 | 33.6 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 7.17 | 13.9 | 15.9 | 17.4 | 33.6 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.28 | 1.73 | 2.08 | 3.13 | 4.97 |
Dividends per Share |